Expand Content

Radiation Oncology Residency


We offer a fully ACGME-accredited four year advanced training program in radiation oncology.  Residents matching at our program are required to complete a separate ACGME-accredited intern year prior to beginning their radiation oncology training.

This superior academic and clinical training program is equipped with the latest radiotherapy and radiosurgery technology and designed to prepare our residents to become future leaders in the practice of radiation oncology.

Cleveland Clinic is a large tertiary care medical center. Accordingly, there is ample clinical experience for residents in training. Residents are exposed to a variety of malignancies and treatments during their training. The department has 2 CT simulators, along with 6 linear accelerators treating up to 150 patients per day.

Experience in intensity modulated radiation therapy (IMRT), Gamma Knife Radiosurgery, stereotactic body radiotherapy (lung, spine, liver, prostate), permanent prostate seed brachytherapy (~7-8 cases/week), total body irradiation, high dose rate brachytherapy, hyperthermia, radioimmunotherapy, and intraoperative radiation are an integral part of Cleveland Clinic's program.

Pediatric experience is gained throughout training and during a dedicated month rotation at St. Jude Children's Research Hospital during the PGY-4 or 5 year.

Curriculum


PGY 2-PGY 5 (Radiation Oncology)
PGY 2

During the PGY-2 year, new resident are immersed in introductory physics and radio-biology course work in addition to exposure to the fundamentals of radiation oncology. Areas covered include work-up, treatment planning process, delivery of radiation and follow up of patients receiving radiotherapy.

PGY 3

During the PGY-3 year, the residents are expected to improve their understanding of all aspects of radiation oncology, especially the treatment planning process, and also to develop a research interest for the following year.

PGY 4

During the PGY-4 year, residents are expected to perform clinical or basic science research for 6-9 months under the supervision of an appropriate Cleveland Clinic faculty member. The remaining time will be spent in electives such as dosimetry and community radiation oncology. One member of the PGY-4 class is selected by the faculty to serve as Chief Resident.

PGY 5

During the PGY-5 year, the level of responsibility is increased. The year is structured to consolidate clinical skills and the knowledge base acquired during the previous three years.

Teaching Conferences

Resident teaching conferences are held daily between 8:00-9:00 am and are staffed by radiation oncology attending physicians and medical physicists. Residents are exempt from clinical duties during these times.

Morning Conference

Case presentation and discussion of a specific disease site, twice per week. Residents and staff discuss anatomy, work-up, imaging, treatment options, and field design. Residents are expected to study and a handout is distributed at the conclusion of the meeting.

Chart Rounds

A conference to discuss the set-up, planning, and techniques of radiation delivery.

Physics and Radiation Biology Lectures

Weekly interactive lectures in physics and radiation biology are given by faculty members for residents in the PGY-2 to PGY-4 years.

Journal Club

Monthly meetings to discuss recent articles in the field.

Radiation Oncology Grand Rounds

Bi-weekly lunch time educational sessions, conferences led by faculty members or residents.

Tumor Board

Regularly scheduled multidisciplinary conferences, attended by medical oncology, surgery, and radiation oncology in the areas of lung, breast, CNS, head & neck, gynecology, gastroenterology, and lymphoma.

Visiting Professor Program

At least four times per year, leaders in radiation oncology are invited to spend a day at Cleveland Clinic. Usually, the invited professor will give a lecture and then spend the morning discussing specific cases or issues in radiation oncology with residents.

Research & Meetings

Resident research activity can begin early at Cleveland Clinic. Although there is a dedicated 6-9 months of research time in the PGY-4 year, many junior residents have oral or poster presentations at national meetings such as ASTRO, ASCO, RSNA, AUA, and SNO.

Cleveland Clinic allows residents to attend a meeting of their choice starting in the PGY-2 year. All residents in their PGY-3, 4, and 5 year typically attend ASTRO.

Additional funding is available within the department for residents who present research at other national meetings.

Benefits
  • Vacation: 15 days (3 weeks) per year + variable number of meeting days and institutional holidays
  • Call Schedule: Home call, one week at a time.
  • Book fund: An individual book fund is available for all residents to purchase texts.
  • Office space: Each resident has personal desk space with a computer and dual monitors. The residents' room is on the 2nd floor (windows!).
  • Pagers: Cleveland Clinic has a text paging system.

There are typically three positions available per year. Cleveland Clinic and the Radiation Oncology Program participate in the Electronic Residency Application Service (ERAS) for the application process and the National Resident Matching Program (NRMP) for the matching of residents to programs.

The internship year is no longer incorporated into the residency program at CCF. Therefore, applicants who match at Cleveland Clinic for radiation oncology residency must complete a separate intern year in an ACGME-accredited program.

Interviews

Applications will be reviewed upon completion and selected candidates will be invited for interviews. Candidates selected for interviews will be notified in November and interviews will typically occur on Mondays in January. The interview schedule begins with an informal evening with the residents at a local restaurant. This is an opportunity for the applicants to get to know the residents and ask questions.

Each candidate is provided with an individualized timetable for their interview day (typically Monday). For all candidates, this includes a program overview over breakfast with the program director at approximately 7:30 am, morning conference beginning at 8:00 am, after which applicants interview with various members of the department. Each candidate will meet with 6-9 faculty members on interview day, including the Chairman, the Program Director, and the Chief Medical Physicist. Interviewees are also given an opportunity to spend some time in the clinic. Prior to completing their final interviews, applicants have another chance to get to know the residents during the informal interview day lunch. The day typically concludes around 2:00 pm, although schedules may vary.

Note

Cleveland Clinic subsidizes a proportion of accommodation fees.

Elective Medical Student Rotations

Fourth year medical students interested in an elective rotation in the Department of Radiation Oncology should contact Danielle Berry regarding availability at berryd2@ccf.org or by phone at 216-445-4379.

Further information about medical student elective rotations at Cleveland Clinic, including requirements, eligibility and the application form can be viewed at the Cleveland Clinic Medical Student Elective Website.

Students who perform electives at Cleveland Clinic are often expected to function as independent residents. Responsibilities include evaluation of patients, dictation, and presentation of a morning conference. Both research and clinical electives are available.

Contact Information

You may obtain additional information about the Radiation Oncology Residency Program by contacting:


Danielle Berry

Department of Radiation Oncology
Cleveland Clinic
9500 Euclid Avenue T-28
Cleveland, OH 44195
Phone: 216.445.4379
Email: berryd2@ccf.org

PGY-5

Gaurav Marwaha, MD

Hometown: Cleveland

Medical School: University of Cincinnati

Hobbies: Exploring Cleveland's Metroparks and Ohio's North Coast, Browns/Indians/Cavs, Bhangra, acoustic guitar, surfing, hoops, tennis, hanging out with my co-residents

Why did you choose Cleveland Clinic? The family-like feel to our residency, I can't imagine a better teaching program, the incredible diversity of colleagues and patients alike that this institution attracts from all over the world

Jason Hearn, MD

Hometown: Portland, OR

Medical School: Harvard Medical School

Hobbies: Hiking Cleveland's gorgeous Metroparks, camping on Lake Erie's islands, catching a Broadway show at Playhouse Square, enjoying architecture and cuisine in Tremont, playing Euro board games in Akron, photographing nature, reading Lovecraft, exploring The Savage Coast, and geocaching

Why did you choose Cleveland Clinic? Excellent didactics, cohesive resident group, very knowledgeable staff, impressive physics department, wide exposure to specialized techniques and uncommon diseases, and a categorical internship (this is well-integrated from a curricular standpoint and is extremely helpful for applicants hoping to couples-match).


Mihir Naik, DO

Hometown: Cerritos, CA

Medical School: Midwestern University

Hobbies: Traveling, photography, reading, TV, stand up comedy

Why did you choose Cleveland Clinic? Cleveland Clinic is a great institution with faculty that are dedicated to teaching and helping make you a better physician and person. In addition, I love working with all of my co-residents who are all fantastic people, incredibly brilliant, and a great resource to discuss challenging cases with.

PGY-4

Neil Woody, MD

Hometown: Toronto, Canada

Medical School: Cleveland Clinic Lerner College of Medicine

Hobbies: Hiking, canoeing, hockey

Why did you choose Cleveland Clinic? The dedicated intern year is structured to allow rotations through radiation related specialties and get to know the clinic and referring physicians. There are dedicated conferences for resident education daily. The mentorship model working directly one on one with a single staff member at a time who is passionate about resident education. Co-residents who are friendly, fun and motivated to add to each other’s learning.


Mike Weller, MD (Chief Resident)

Hometown: Orlando, FL

Medical School: University of Miami School of Medicine

Hobbies: I'm an ACC sports fan marooned Big 10 country. I love to travel, spend too much money at restaurants, and watch way too many movies and TV shows. Most importantly, I love spending time hanging out with my wife and playing with our dog.

Why Cleveland? Cleveland has great, affordable housing and a fantastic park system. It's an excellent food and beer town with diverse local cuisine (Michael Symon's restaurants, Little Italy, AsiaTown, etc.) In my neighborhood alone, my wife and I can walk to an independent movie theater, a brewery, a local wine and beer shop, and a probably a dozen restaurants, most of which have patios to take advantage of the great summer weather. But some of my favorite times have been grilling out in our backyard with good friends and family.

Why did you choose Cleveland Clinic? Aside from all of the benefits associated with training in a world class hospital and cancer center, I believe our faculty's uncompromised dedication to resident teaching is truly unique.


Jeff Kittel, MD

Hometown: Wilton, CT

Medical School: Washington University in St. Louis

Hobbies: Baseball, Cleveland's amazing microbrewery scene, the West Side Market, biking

Why did you choose Cleveland Clinic? The family-like relationship among the residents, our excellent educational curriculum, and the chance to learn from amazing teachers


Steven Oh, MD

Hometown: Portland, OR

Medical School: Yale

Hobbies: Boxing, Snowboarding, Surfing, Tennis, Traveling

Why did you choose Cleveland Clinic? For the best group of faculty and residents to work with.

PGY-3

Yvonne Thanh-Nga Pham, MD

Hometown: Orange County, CA

Medical School: University of California at Davis- Sacramento, CA

Hobbies: Beginner golfer. I also enjoy tennis, running, traveling and photography.

Why did you choose Cleveland Clinic? The specialty tailored intern year at Cleveland Clinic gives you great hands-on experience with the medical and surgical fields related to radiation oncology. You have a chance to assist with relevant oncologic surgeries and follow patients in their post-op recovery. On the Heme/Onc and palliative rotations, you learn about pain management and how to care for patients in the context of their cancer. The breadth of exposure to these related fields has been invaluable to my training


Matt Ward, MD

Hometown: Alpharetta, GA

Medical School: Medical College of Georgia

Hobbies: Teasing Rupesh, traveling, reading, camping, whitewater, snowboarding, hanging out with my wife

Why did you choose Cleveland Clinic? I chose Cleveland Clinic partly for the excellent clinical experience but mostly because of the cordial atmosphere with a strong dedication to resident education. I chose Cleveland because the Cleveland Clinic is here. I have enjoyed Cleveland’s diverse communities, restaurants and music.


Rupesh Kotecha, MD

Hometown: Midland, MI

Medical School: MSU College of Human Medicine

Hobbies: Spending more time at Cheesecake Factory than at the hospital, Playhouse Square, Cleveland Orchestra

Why did you choose Cleveland Clinic? The focus of the department and the staff on resident education and the residency program.

PGY-2

Ehsan Balagamwala, MD

Hometown: St. Louis, MO

Medical School: Cleveland Clinic Lerner College of Medicine

Hobbies: Photography, traveling, basketball

Why did you choose Cleveland Clinic? My decision to pursue residency training at Cleveland Clinic was influenced by our faculty’s incredible dedication to education, balanced approach to clinical service and education, the collegiality of the residents and the excellent research opportunities. One of the other strengths of our program is the integrated intern year which exposes interns to a wide variety of oncologic specialties integrating us into oncology from day 1 and providing exposure to (an opportunity to learn from) referring doctors and specialties. In terms of patient population, we get exposed to a good mix of bread-and-butter cases as well as once-in-a-lifetime type of cases thereby giving us not only breadth but also depth in our educational experience.


Camille Berriochoa, MD

Hometown: Boise, ID

Medical School: University of Washington School of Medicine

Hobbies: Running, mountain biking, hiking, skiing, traveling, learning Spanish, salsa dancing, reading, cooking, hosting dinner parties, baking

Why did you choose Cleveland Clinic? The Cleveland Clinic radiation oncology program provides training that is both rigorous and nurturing at the same time. The attending physicians are here not only to provide excellent clinical care but to push their trainees to gain a deep understanding of radiation oncology and cancer management in general. Additionally, my co-residents are kind, fun, easygoing, and incredibly helpful. In terms of the city itself, this is a place that offers big city activities without the associated hassle. From its world renowned symphony to its numerous Broadway offerings, multiple professional sports teams (records aside!), and delicious restaurants, there are myriad activities to enjoy. I greatly look forward to spending four more years here.


Charles Marc Leyrer, MD

Hometown: Cary, NC

Medical School: Wake Forest

Hobbies: Reading, cooking, snowboarding, board games, racquetball, home-brewing, golfing, camping

Why did you choose Cleveland Clinic? I decided to come here after doing my away rotation here. The program itself was tough but it was in the name of making you a great evidence-based physician and I knew it was a program that would help me excel. The dedicated intern year was a great in that it allowed you interaction with many other specialties with opportunities you might not normally have access to. The main reason I came here was the residents were very welcoming and supportive of each other and they were the kind of group I wanted to be part for my residency.

PGY-1

Aditya Juloori, MD

Hometown: Cleveland, OH

Medical School: Baylor College of Medicine, TX








Bindu Manyam, MD

Hometown: Detroit, MI

Medical School: Case Western Reserve University School of Medicine, OH

Publications 2014
Papers in Peer-Reviewed Journals
  1. Balagamwala EH, Djemil T, Marina O, Reddy CA, Suh JH, Xia P, Angelov L, Chao ST. Repeat stereotactic body radiotherapy for recurrent spinal tumors is feasible with accurate assessment of cumulative spinal cord dose. J Radiat Oncol July 2013.
  2. Kotecha R, Angelov L, Barnett G, Reddy C, Suh J, Murphy E, Neyman G, Chao S. Calvarial and skull base metastases: expanding the clinical utility of gamma knife radiosurgery. Journal of Neurosurgery. 2014
  3. Kotecha R, Ward M., Koyfman S. Organ preservation in patients with locally-advanced larynx cancer: important principles and treatment considerations. Applied Radiation Oncology.2014
  4. Xiang J., Luo Q., Kotecha R., Korman A., Zhang F., Luo H., Fujiwara H., Hemasilpin N., Rose D. Accumulated Source Imaging of Brain Activity with Both Low and High-Frequency Neuromagnetic Signals. Frontiers in Neuroinformatics. May 1, 2014.
  5. Kumar AMS, Woody NM, Djemil T, Videtic GMM, Stephans KL. Synchronous Non-Small Cell Lung Cancer Nodules Treated with Stereotactic Body Radiation Therapy (SBRT). J Radiosurg SBRT, 2014; 3(1), 81-88
  6. Fredman ET, Kumar AMS, Abdel-Wahab M. Ten-Year Comparison of 165 Patients treated with MRT and 3D Conventional Radiation Therapy for Anal Cancer. Gastrointest Cancer Res. 2014.
  7. Kumar AMS, Woody NM, Djemil T, Videtic GMM, Stephans KL. Synchronous Non-Small Cell Lung Cancer Nodules Treated with Stereotactic Body Radiation Therapy (SBRT). J Radiosurg SBRT. 2014.
  8. Call JA, Naik M, Rodriguez FJ, Giannini C, Wu W, Buckner JC, Parney IF, Laack NN. Long-term Outcomes and Role of Chemotherapy in Adults With Newly Diagnosed Medulloblastoma American Journal of Clinical Oncology, Vol. 37, Issue 1, Feb 2014, Pages 1-7
  9. Shukla ME, Yu Changhong, Reddy C, Stephans KL, Abdel-Wahab M, Ciezki J, Tendulkar RD. Evaluation of the Current Prostate Cancer Staging System Based on Cancer-Specific Mortality in the Surveillance, Epidemiology, and End Results Database. Clinical Genitourinary Cancers. 2014
  10. Ward MC, Ciezki JP, Stephans KL. Brachytherapy. In: Khanna, Bratslavsky and Stein. Surgical Techniques for Prostate Cancer. New York, NY; 2014
  11. Ward MC, Tendulkar RD, Ciezki JP, Klein EA. “Future Directions from Past Experience: A Century of Prostate Radiotherapy.” Clinical Genitourinary Cancer2(1):13-20, 2014.
  12. Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy. Stereotactic Funct Neurosurg.2014; 92(1):53-8.
  13. Stephans K, Djemil T, Diaconu C, Reddy C, Xia P, Woody N, Greskovich J, Makkar V, Videtic G. Esophageal dose tolerance to hypofractionated stereotactic body radiotherapy: Risk factors for late toxicity. IJROBP, 2014
Book Chapters
  1. Jung E, Lo SS, Sahgal A, Chang EL, Suh JH, Balagamwala E, Chao ST. Chapter 1: Overview of SBRT for Spinal Metastases. In: Lo S, Sahgal A, Teh BS, Gerszten P, Chang EL. Stereotactic Body Radiation Therapy: Spinal Metastasis, 1st edition. Expert Reviews Ltd. 2013.
  2. Hearn J, Videtic GMM. “Radiotherapy Planning for Thoracic Malignancies.” “Handbook of Treatment Planning in Radiation Oncology, 2nd edition. New York, NY: Demos Medical; 2014.
  3. Kittel J, Macklis R. Chapter 10: Lymphoma and Myeloma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  4. Kotecha R, Chao S, Murphy E, Suh J. Chapter 28: Benign Intracranial Disease: Benign Tumors of the Central Nervous System, Arteriovenous Malformations, and Trigeminal Neuralgia. Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy. Springer; 2014 edition.
  5. Kotecha R, Cherian S. Chapter 9: Gynecologic radiotherapy. Handbook of Treatment Planning in Radiation Oncology, 2nd Edition. Demos Medical Publishing; 2014 edition.
  6. Kumar AMS, JF Greskovich, SA Koyfman. Head and Neck Cancers. In: GMM Videtic. Handbook of Planning Treatment in Radiation Oncology 2nd edition. NY: Demos Medical; 2014.
  7. Marwaha G, Vassil A, Videtic G. Chapter 13: Palliative Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  8. Oh S, Tendulkar R. Chapter 5: Breast Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  9. Shukla ME, Stephan KL, Abdel-Wahab M. «Gastrointestinal Radiotherapy. In: GMM Videtic. Handbook of Planning Treatment in Radiation Oncology 2nd edition. “NY: Demos Medical; 2014.
  10. Weller M, Murphy E. Chapter 12: Pediatric Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  11. Woody NM, Murphy ES, Stephans KL and Amarnath SA. Chapter 9: Sarcoma Radiotherarpy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  12. Woody N, Stephans K, Chao S, Murphy E. Chapter 11: Soft Tissue Sarcoma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
  13. Woody N, Videtic G. Chapter 2: Tools for Simulation and Treatment. In Handbook of Treatment Planning in Radiation Oncology, Second edition. New York, NY, Demos Medical 2014.
Publications 2013
Papers in Peer-Reviewed Journals
  1. Guo S, Balagamwala EH, Reddy C, Elson P, Chao ST, Videtic GM, Suh JH. Clinical and Radiographic Outcomes from Repeat Whole Brain Irradiation for Brain Metastases in the Age of Stereotactic Radiosurgery. Revision to Am J Clin Oncol Oct 2013.
  2. Balagamwala EH, Djemil T, Marina O, Reddy CA, Suh JH, Xia P, Angelov L, Chao ST. Repeat stereotactic body radiotherapy for recurrent spinal tumors is feasible with accurate assessment of cumulative spinal cord dose. Accepted J Radiat Oncol July 2013.
  3. Hunter G, Balagamwala E, Koyfman S, et al. The Efficacy of External Beam Radiotherapy and Stereotactic Body Radiotherapy (SBRT) for Painful Spinal Metastases from Renal Cell Carcinoma. Pract Rad Oncol. 2013
  4. Hearn J, Reddy CA, Weller MA, Kotecha RR, Marwaha G, Ciezki JP, Stephans KL, and Tendulkar RD. “Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-Risk Factors is Not a Valid Surrogate for High-Risk Disease.” International Journal of Radiation Oncology, Biology, Physics. 2013; 87(2):S156.
  5. Marwaha G, Reddy C, Weller MA, Kotecha R, Hearn JWD, Ciezki JP, Stephans KL, and Tendulkar RD. Gleason Pattern 5: Is Adverse Really Worse? International Journal of Radiation Oncology, Biology, Physics. 2013; 87(2):S351-S352.
  6. Marwaha G, Barrett WL. Stage III and IV head and neck cancer: Does everyone need chemotherapy? Intl J Head and Neck Surg 2013
  7. Kotecha R., Venkatramani R., Jubran R. F., Arkader A., Olch A. J., & Wong K. “Clinical Outcomes of Radiation Therapy in the Management of Langerhans Cell Histiocytosis.” American Journal of Clinical Oncology.2013
  8. Chandana S, Kotecha R, Al-Janadi A, Chang H, Conley B. “Rare Case of Hairy Cell Leukemia With Brain Parenchymal Involvement: A Diagnostic Dilemma.” Journal of Clinical Oncology. Apr 10, 2013:e186-e188.
  9. Stockham AL, Reddy CA, Kumar A, Ahluwalia M, Murphy ES , Suh JH, Vogelbaum MA, Barnett GH, Chao ST. “Results of a Questionnaire Regarding Practice Patterns for the Diagnosis and Treatment of Intracranial Radiation Necrosis After SRS.” J Neurooncol. 2013. 115(3): 469-75.
  10. Kumar AMS, Woody N, Djemil T, Videtic GMM, Stephans KL. Synchronous non -small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT). J Radiosurgery and SBRT
  11. Leyrer M, Chan M, Peiffer A, Horne E, Harman M, Carter A, Hinson H, Mirlohi S, Duncan S, Dietrich A, Lessner G. Taste and smell disturbances after brain irradiation: A dose-volume histogram analysis of a prospective observational study. Practical Radiation Oncology Vol. 4 Iss. 2 March-April 2014.
  12. Shukla M, Kumar A, Godley A, Khuntia D. Imaging and radiation therapy: Current trends and future possibilities. Applied Radiation Oncology. February 2013; 6-12.
Publications 2012-2013
Papers in Peer-Reviewed Journals
  1. Chao ST, Ahluwalia MS, Barnett GH, Stevens, GH, Murphy ES, Stockham AL, Shiue K, Suh JH. Challenges with the Diagnosis and Treatment of Cerebral Radiation Necrosis. Int J Radiat Oncol Biol Phys, accepted for publication.
  2. Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH. Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol. 2012 Jul 20;7:110.
  3. Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, Vogelbaum MA, Videtic GM. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer. 2012 Aug;77(2):389-93.
  4. Kumar A, Bui C, Nasta S, Schuster SJ, Plastaras JP. Case Series: Intensity Modulated Radiotherapy to Treat Limited Stage Non-Endemic Nasal Natural Killer/T Cell Lymphoma. Int J Hematol. 2012; 8 (1), e-published.
  5. Kumar SS, Stockham AL, Chao ST, Ahluwalia M, Suh JH. Radiation necrosis: Now you see it, now you don’t. Applied Radiat Oncol. 2013 February: 24-27.
  6. Marwaha G, Wilkinson A, Bena J, Macklis R, Singh A. Dosimetric Benefit of a New Ophthalmic Radiation Plaque. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84 (5) : 1226-1230.
  7. Shukla ME, Kumar AMS, Godley A, Khuntia D. Imaging and radiation therapy: Current trends and future possibilities. Applied Radiat Oncol, February 2013.
  8. Stockham AL, Tievsky AL, Koyfman SA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST. Standard MRI Findings Do Not Reliably Distinguish Radiation Necrosis from Tumor Recurrence. J Neurooncol. 2012 Aug;109(1): 149-58.
  9. Stockham AL, Suh J, Chao S. Difficult Cases: Management of Recurrent Brain Metastasis after Radiosurgery. In: Kim, Dong Gyu and Lunsford, L Dade. Currentand Future Management of Brain Metastasis, A Volume in 'Progress in Neurological Surgery'. Prog Neurol Surg. 2012; 25: 273-86.
  10. Stockham AL, Chao ST, Suh JH. Wanted Dead or Alive? Distinguishing radiationnecrosis from tumor progression after stereotactic radiosurgery. Applied Radiat Oncol. 2012; (1):26-29.
  11. Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore HC, Budd GT, Dietz J, Crowe JP, Macklis R. Impact of Post-mastectomy Radiation on Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated With Modern Systemic Therapy. Int J Radiat Oncol Biol Phys. 2012; 83(5): e577–e581.
Book Chapters
  1. Chao S, Marwaha G. CNS Malignancies. In: Suh, J. Radiation Oncology Self-Assessment Guide: A Question & Answer Review. New York, NY: Demos Medical; 2012: 53-118.
  2. Koyfman, SK, Shukla ME. Head and Neck Cancers. In: Suh, J. Radiation Oncology Self-Assessment Guide. New York, NY: Demos Medical; 2012: 3-47.
  3. Murphy E, Guo S, Marwaha G. Pediatric Malignancies. In: Suh, J. Radiation Oncology Self-Assessment Guide: A Question & Answer Review. New York, NY: Demos Medical; 2012: 497-552.
  4. Stephans KL, Kumar A. Genitourinary Cancers. In: Suh, J. Radiation Oncology Self-Assessment Guide. NY: Demos Medical; 2012: 305-60.
Presentations 2014
Presentations
  1. Berriochoa C, Kumar A, Khorana A, Walsh M, Wahab M. Preoperative chemoradiation for locally advanced pancreatic cancer improves margin negativity and nodal involvement at resection. Poster Presentation, 56th annual meeting of the American Society of Radiation Oncology, Sept.2014
  2. Berriochoa C, Videtic G, Djemil T, Woody N, Stephans K "Lung SBRT for T3N0 tumors with chest wall invasion: Safe and Effective" Poster Presentation, 56th annual meeting of the American Society of Radiation Oncology, Sept. 2014
  3. Tseng C, Thibault I, Atenafu E, Chao S, Al-Omair A, Boehling J, Balagamwala E, Cunha M, Angelov L, Brown P, Suh J, Rhines L, Fehlings M, Chang D, Sahgal A. De Novo vs. Progression of the Existing Vertebral Compression Fracture (VCF) Following Spine Stereotactic Body Radiotherapy (SBRT): Separate Risk Profiles to Consder. 56th ASTRO 2014 Annual Meeting, San Francisco, CA, September 15, 2014.
  4. Thibault I, Atenafu E, Chang E, Chao S, Al-Omair, Boehling N, Balagamwala E, Cunha M, Angelov L, Brown P, Suh J, Rhines L, Fehlings M, Sahgal A. Factor influencing vertebral compression fracture specific to renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study. 56th ASTRO 2014 Annual Meeting, San Francisco, CA, September 15, 2014.
  5. Hearn JW, Yard BD, Adams DJ, Tamayo P, Schreiber SL, Meyerson ML, Hammerman PS, Abazeed ME. Integrative Radiogenomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Adenocarcinomas of the Lung. Oral presentation at 56th ASTRO Annual Meeting, San Francisco, CA, September 16, 2014.
  6. Kittel J, Lee J, Woody N, Zimmerman A, Murphy E, Barnett G, Vogelbaum M, Stevens G, Suh J, Chao S. Adjuvant radiation may not be necessary following gross total resection of an atypical meningioma. ASTRO Sept. 2014, poster presentation.
  7. Kotecha R, Angelov L, Barnett G, Reddy C, Suh J, Murphy E, Neyman G, Chao S. Calvarial and skull base metastases: expanding the clinical utility of gamma knife radiosurgery. 17th International Leksell Gamma Knife Society Meeting. New York, NY. May 11-15, 2014
  8. Kotecha R, Marwaha G, Hearn J, Weller MA, Kupelian PA, Reddy CA, Ciezki JP, Stephans KL, Tendulkar RD. “A Comparison of Long-Term Treatment-Related Toxicities Between Moderately Hypofractionated and Conventionally Fractionated Radiation Therapy for Localized Prostate Cancer.” Poster presentation at 56th ASTRO 2014 Annual Meeting, San Francisco, CA, Sept. , 2014.
  9. Kumar A, Juliano J, Walsh M, Chalikonda S, Stephans K. HDR Brachtherapy for Resected Retroperitoneal Sarcoma in the Primary and Recurrent Setting Poster Presentation at 56th ASTRO Annual Meeting, San Francisco, CA, Sept. 2014.
  10. Marwaha G, Medina C, Naik M, Ward MC, Wilkinson A, Singh AD. Ruthenium Eye Plaques for Uveal Melanoma: Long term clinical outcomes. American Society for Radiology Oncology (ASTRO) 56th Annual Meeting; Sept. 2014
  11. Naik M, Reddy CA, Stephans KL, Tendulkar RD. Post-Treatment PSA 6 months after Radiation and Androgen Deprivation Therapy Predicts for Distant Metastases and Prostate Cancer Specific Mortality. American Society for Radiology Oncology (ASTRO) 56th Annual Meeting; September 14-17, 2014, San Francisco, CA. Accepted for Oral Presentation
  12. Oh SC, Tariq MB, Stephans KL, Ciezki JD, Tendulkar RD. “Outcomes in Organ Transplant Patients with Prostate Cancer Treated with Radiotherapy.” Poster presentation at 2014 ASTRO. San Francisco, CA. Sept. 2014.
  13. Pham YD, Kittel JA, Reddy CA, Ciezki JP, Stephans KL, Tendulkar RD. “Improved biochemical control after permanent prostate seed implantation for large prostate glands >60 grams compared to smaller glands.” 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO); Sept. 2014.
  14. Shukla ME, Ward MC, Stephans KL, Reddy CA, Garcia JA, Stephenson AJ, Rini BI, Klein EA, Tendulkar RD. “Early Salvage Pelvic Radiotherapy For Lymph Node Positive Prostate Cancer Following Prostatectomy.” 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO); Sept. 2014.
  15. Bhateja P, Ward M, Bledsoe T, Reddy C, Burkey B, Abazeed M, Adelstein D, Nwizu T, Greskovich J, Koyfman S. “Definitive Chemoradiation (CRT) for Organ Preservation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx (SCC-HP): Oncologic Outcomes and Late Toxicity.” 56th ASTRO Annual Meeting; Sept. 2014
  16. Ward M, Bhateja P, Bledsoe T, Reddy C, Adelstein D, Nwizu T, Greskovich J, Burkey B, Xia P, Koyfman S. “Nasogastric Enteral Feeding is Superior to Percutaneous Gastrostomy in Preventing Late Pharyngeal Dysfunction in Long-term Survivors of Locoregionally Advanced Head and Neck Squamous Cell Cancer (HNSCC) treated with Definitive Chemoradiotherapy (CRT).” 56th ASTRO Annual Meeting; Sept. 2014.
  17. Ward M, Bhateja P, Bledsoe T, Reddy C, Adelstein D, Nwizu T, Greskovich J, Burkey B, Xia P, Koyfman S. Reduction of Severe Late Toxicity After Definitive Chemoradiotherapy (CRT) using Intensity Modulated Radiation Therapy (IMRT) in Non-HPV Associated Head and Neck Squamous Cell Cancer (HNSCC): More than Xerostomia. 56th ASTRO Annual Meeting; Sept. 2014.
  18. Weller MA, Reddy CA, Kittel J, Smith K, Tendulkar RD, Stephans KL, Klein EA, Angermeier KW, Ulchaker J, Campbell S, Stephenson A, Ciezki JP. “Comparison of outcomes between brachytherapy and intensity modulated radiotherapy in high risk prostate cancer.” 56th ASTRO Annual Meeting; Sept., 2014.
  19. Woody NM, Durand P, Naik M, Elegbede A, Duraes E, Coopey SB, Dietz J, Djohan R, Tendulkar RD. “Impact of breast radiotherapy on late toxicities and reoperation following mastectomy with tissue expander based reconstruction.” American Society for Radiology Oncology (ASTRO) 56th Annual Meeting; Sept. 2014, San Francisco, CA. Accepted for Oral Presentation
  20. Stephans KL, Woody NM, Reddy CA, Magnelli A, Zhaung T, Djemil T, Videtic GMM "Time Will Tell: Is 60 Gy in 3 Fractions the Optimal SBRT Schedule for Stage I Non-Small Cell Lung Cancer? " Oral Presentation, 56th annual meeting of the American Society of Radiation Oncology, September 2014
  21. Brigotti S, Stephans KL, Reddy CA, Djemil T, Woody NM, Videtic GMM "The Influence of Hematological Parameters on Tumor Control and Survival in Lung SBRT" Poster Presentation 56th annual meeting of the American Society of Radiation Oncology, September 2014
  22. Videtic GMM, Reddy CA, Woody NM, Djemil T, Stephans KL "5 years and beyond: Characterizing long term survivors after stereotactic body radiotherapy (SBRT) for early stage lung cancer” Poster Presentation 56th annual meeting of the American Society of Radiation Oncology, September 2014
Presentations 2013
Presentations
  1. Hearn J, Reddy CA, Weller MA, Kotecha RR, Marwaha G, Ciezki JP, Stephans KL, and Tendulkar RD. “Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-Risk Factors is Not a Valid Surrogate for High-Risk Disease.” Digital poster discussion at 55th ASTRO Annual Meeting, Atlanta, GA, September 22, 2013.
  2. Hearn J, Reddy CA, Weller MA, Kotecha RR, Marwaha G, Ciezki JP, Stephans KL, and Tendulkar RD. “Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-Risk Factors is Not a Valid Surrogate for High-Risk Disease.” Poster presentation at 33rd Annual Cleveland Clinic Research Day, Cleveland, OH, October 10, 2013.
  3. Kittel J, Reddy CA, Ulchaker J, Angermeier KW, Stephans KL, Tendulkar RD, Chehade N, Altman A, Klein E, Ciezki JP. “A Significant Cause of Variability in Prostate Brachytherapy Outcomes as Demonstrated from a Single Institution Suggesting a Method for Uniform Reporting among Institutions.” ASTRO 2013 Annual Meeting.
  4. Weller MA, Kupelian PA, Reddy CA, Kotecha R, Ciezki JP, Klein EA, Stephans KL, Tendulkar RD. “Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a Comparison to Standard Dose-Escalated RT.” ASTRO 2013 Annual Meeting. Atlanta, GA.
  5. Marwaha G, Reddy CA, Weller MA, Kotecha R, Hearn J, Ciezki JP, Stephans KL, Tendulkar RD. “Gleason Pattern 5: Is Adverse Really Worse?” ASTRO 2013 Annual Meeting. Atlanta, GA.
  6. Kumar, NM Woody, T Djemil, GMM Videtic, KL Stephans.” Synchronous Non-Small CellLung Cancer Nodules Treated with Stereotactic Body Radiation Therapy (SBRT).” American Radium Society 2013, Scottsdale, AZ, May 1, 2013
  7. Oh SC, Gales JB, Reddy C, Yu JS, Murphy EM, Suh JH, Chao SC. “Reirradiation of Recurrent Gliomas.” (Poster presentation)2013 ASTRO. Atlanta, GA. September 22-25, 2013.
  8. Shukla ME, Rehman S, Reddy CA, Macklis R, Budd GT, Moore HC, Crowe JP, Dietz J, Tendulkar RD. “Influence of Receptor Status and Response to Neoadjuvant Chemotherapy on Outcomes of Patients Treated with Mastectomy for Invasive Breast Cancer.” 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO); September 23, 2013
  9. Weller MA, Tendulkar RD, Reddy CA, Stephans KL, Kupelian PA. “Adjuvant vs Neoadjuvant Androgen Deprivation with Radiation Therapy for Prostate Cancer: Does Sequencing Matter?” Poster presentation at ASCO GU February 14th, 2013
  10. Woody NM, Stephans KL, Raymond D, Chao ST, Suh J, Videtic GMM "Non- small cell lung cancer with single brain metastasis at initial presentation: Patterns of failure after radiosurgery without whole brain radiation therapy" CCF, 55th annual meeting of the American Society of Radiation Oncology, 09/2013 (Poster)
Resident Presentations 2012-2013
Presentations
  1. Abdel-Wahab M, Yu C, Fredman ET, Kumar AMS, El-Gazzaz G, Aucejo FN, Coppa C, Kattan M. Prediction of hepatocellular carcinoma recurrence after primary treatment using nomograms. Presented at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  2. Guo S, Reddy CA, Stephans KL, Videtic GM. Outcomes of Hypofractionated Radiation Therapy in Poor Risk NonSmall Cell Lung Cancer Patients and Validation of RTOG 0213. Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  3. Hearn J, Videtic GMM, Djemil T, and Stephans KL. Salvage Stereotactic Body Radiotherapy (SBRT) for Local Failure after Upfront Lung SBRT: If at First You Don't Succeed... Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  4. Hearn J, Reddy CA, Weller MA, Kotecha RR, Marwaha G, Ciezki JP, Stephans KL, and Tendulkar RD. Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-Risk Factors is Not a Valid Surrogate for High-Risk Disease. Poster Discussion at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  5. Kittel J, Reddy C, Ulchaker J, Angermeier K, Stephans KL, Tendulkar R, Chehade N, Altman A, Klein E, Ciezki JP. A Significant Cause of Variability in Prostate Brachytherapy Outcomes as Demonstrated from a Single Institution Suggesting a Method for Uniform Reporting among Institutions. Presented at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  6. Kumar AMS, Falk G, Stephans KL, Walsh M, Pelley , Abdel-Wahab M. Influence of Adjuvant Treatment on Outcomes in Resectable Pancreatic Cancer. ASTRO 2013; September 22-25, 2013; Atlanta, GA.
  7. Kumar AMS, El-Gazzaz G, Aucejo F, Abdel-Wahab M. Outcomes of Liver Resection for Hepatocellular Carcinoma Patients: A Cleveland Clinic Experience. Poster Discussion at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  8. Kumar AMS, Mehta A, Kiran R, Kalady M, Lavery I, Abdel-Wahab M. Peri-operative Complications in Patients with Inflammatory Bowel Disease who Received Chemoradiation for Colorectal Malignancy. Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  9. Kumar AMS, Bledsoe T, Noble A, Shang Q, Saxton JP, Rodriguez CP, Adelstein DJ, Koyfman SA, Xia P, Greskovich JF. A Dosimetric Analysis of 3D vs. IMRT Planning and its Impact on Acute Grade 3 Dysphagia and Xerostomia in Oropharyngeal Cancer Patients Treated with Chemoradiotherapy. Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  10. Kumar AMS, Videtic GMM, Woody N, Djemil T, Stephans KL. Synchronous Non-Small Cell Lung Cancer Nodules Treated with Stereotactic Body Radiation Therapy (SBRT). Presented at the Multidisciplinary Thoracic Oncology Symposium 2012; September 6-8, 2012; Chicago, IL.
  11. Kumar A, Woody NM, Djemil T, Videtic GMM, Stephans KL. Presented at American Radium Society 2013; May 1, 2013; Scottsdale, AZ.
  12. Marwaha G, Reddy C, Stephans KL, Videtic GM. Lung lesions treated with SBRT: Does size matter? Presented at 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology; September 6, 2012; Chicago, IL.
  13. Marwaha G, Reddy C, Stephans KL, Videtic GM. Lung lesions treated with SBRT: Does size matter? Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  14. Marwaha G, Reddy C, Weller M, Kotecha R, Hearn JWD, Ciezki JP, Stephans KL, Tendulkar R. Gleason Pattern 5: Is Adverse Really Worse? Presented at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  15. Oh S, Gales JM, Reddy CA, Murphy ES, Yu JS, Suh JH, Chao SC. Reirradiation of Gliomas. Presented at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  16. Shukla ME, Reddy C, Yu C, Abdel-Wahab M, Stephans KL, Tendulkar RD. Redefining Stage IV Prostate Cancer - Is There a Subset Who May be Cured? Oral Presentation at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO); September 25, 2013, Atlanta, GA
  17. Shukla ME, Rehman S, Reddy CA, Macklis R, Budd GT, Moore HC, Crowe JP, Dietz J, Tendulkar RD. Influence of Receptor Status and Response to Neoadjuvant Chemotherapy on Outcomes of Patients Treated with Mastectomy for Invasive Breast Cancer. Presented at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO); September 23, 2013; Atlanta, GA
  18. Shukla ME, Mir MC, Stephenson AJ, Stephans KL, Klein EA, Tendulkar RD. Pre-radiotherapy PSA Is Predictive Of Biochemical Progression Free Survival Following Post-prostatectomy Salvage Radiotherapy. Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
  19. Song A, Kumar AMS, Murphy ES, Tekautz T, Suh JH, Recinos V, Chao ST. Adult Medulloblastoma: Survival, Recurrence, and Prognostic Factors. Society or Neurological Oncology 2013; November 21-24, 2013; San Francisco, CA.
  20. Weller M, Kupelian P, Reddy C, Kotecha R, Ciezki J, Klein E, Stephans K, Tendulkar R. Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a Comparison to Standard Dose-Escalated RT. Poster Discussion at the American Society for Radiology Oncology (ASTRO) 55th Annual Meeting; September 22-25, 2013; Atlanta, GA.
  21. Weller M, Tendulkar R, Reddy C, Stephans R, Kupelian P. Adjuvant vs. Neoadjuvant Androgen Deprivation with Radiation Therapy for Prostate Cancer: Does Sequencing Matter? Presented at the Genitourinary Cancers Symposium; February 14-16, 2013; Orlando, FL.
  22. Videtic G, Reddy C, Marwaha G, Woody N, Djemil T, Stephans K. Mature Experience in Stereotactic Body Radiotherapy for Early Stage Medically Inoperable Lung Cancer at Cleveland Clinic. Presented at the American Society for Radiology Oncology (ASTRO) 54th Annual Meeting; October 28-31, 2012; Boston, MA.
Lectures
  1. Shukla ME. Radiation-Induced Liver Disease. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. December 21, 2012.
  2. Kumar A. Dysphagia. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. October 26, 2012.
  3. Marwaha G. Androgen Deprivation Therapy. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. September 21, 2012.
  4. Guo S. Clinical and Radiographic Outcomes from Repeat Whole Brain Irradiation. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. September 7, 2012.
  5. Hearn J. Radiation-Induced Optic Neuropathy. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. April 19, 2013.
  6. Kittel J. Radiation Myelopathy. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. April 5, 2013.
  7. Stockham. Radionecrosis of the Brain. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. August 17, 2012.
  8. Weller M. Radiation Dermatitis. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. November 16, 2012.
  9. Woody N. Radiation-induced Heart Disease. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. April 26, 2013.
  10. Oh S. Radiation Pneumonitis. Radiation Oncology Grand Rounds. Cleveland Clinic; Cleveland, OH. March 16, 2013.
Recent Graduates from the Radiation Oncology Residency Program
Former Resident Medical School Current Position
Arya Kumar, MD (2014) Case Western Reserve University School of Medicine, Cleveland, OH University Hospitals, Cleveland, OH
Monica Shukla, MD (2014) Vanderbilt University School of Medicine, Nashville, TN Medical College of Wisconsin, Milwaukee, WI
Susan Guo, MD (2013) Columbia University, New York, NC Albuquerque, NM
Abigail Stockham, MD (2013) University of Iowa, Iowa City, IA Harvard University, Boston, MA
Grant Hunter, MD (2012) University of Virginia, Charlottesville, VA Intermountain Healthcare, Salt Lake City, UT
Lawrence Sheplan, MD (2012) University of Puerto Rico, San Juan, Puerto Rico San Juan, Puerto Rico
Shlomo Koyfman, MD (2011) Yale University, New Haven, CT Cleveland Clinic, Cleveland, OH
Mohammad Khan, MD, PhD (2011) University of Tennesse, Memphis, TN Emory University Hospital, Atlanta, GA
Michael Burdick, MD (2010) Virginia Commonwealth University, Richmond, VA Parma Hospital, Parma, OH
Erin Murphy, MD (2010) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Andrew Vassil, MD (2010) University of Medicine and Dentistry of New Jersey, New Brunswick, NJ Cleveland Clinic, Cleveland, OH
Clifford Robinson, MD (2009) Case Western Reserve University, Cleveland, OH Washington University, St. Louis, MO
Kevin Stephans, MD (2009) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Carryn Anderson, MD (2008) U. Texas Medical Branch, Galveston, TX University of Iowa, Iowa City, IA
Rahul Tendulkar, MD (2008) University of Michigan, Ann Arbor, MI Cleveland Clinic, Cleveland, OH
Heath Mackley, MD (2007) University of Pennsylvania, Philadelphia, PA Penn State Hershey Medical Center, Hershey, PA
Justin Juliano, MD (2007) SUNY Upstate, Syracuse, NY Penn State Hershey Medical Center, Hershey, PA
Samuel Chao, MD (2006) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Vipul Thakkar, MD (2006) University of Florida, Gainesville, FL Southeast Radiation Oncology Group, Charlotte, NC
Ratna Sajja, MD (2005) Case Western Reserve University, Cleveland, OH Cancer Care Associates, McKinney, TX
Aimee Quan, MD (2005) University of Cincinnati, Cincinnati, OH Kaiser / Los Angeles Medical Center, Los Angeles, CA
Tom Carlson, MD (2004) University of Arizona, Tucson, AZ Wenatchee Valley Medical Center, Wenatchee, WA
Deepak Khuntia, MD (2004) University of Illinois at Chicago, Chicago, IL Varian Medical Systems, Palo Alto, CA
Chandrika Patel, MD (2003) Washington University, St. Louis, MO St. John Cancer Center, Anderson, IN
Mohammad El Shaikh, MD (2003) Ain Shams University, Cairo, Egypt Henry Ford Health System, Detroit, MI
Jeffrey Buchsbaum, MD, PhD. (2002) Johns Hopkins University, Baltimore, MD Indiana University Midwest Proton Center, Indianapolis, IN
Jason Seavolt, MD (2002) Medical College of Ohio, Toledo, OH Riverside Methodist Medical Center, Columbus, OH
Teresa Davies-Johns, MD (2001) NE Ohio Univ. College of Medicine, Rootstown, OH  
Lav Goyal, MD (2001) Case Western Reserve University, Cleveland, OH Associates in Radiation Oncology, Parkland, FL
Mark Chidel, MD (2000) University of Michigan, Ann Arbor, MI Summit Radiation Oncology, Littleton, CO
Janice Lyons, MD (2000) Chicago Medical School, Chicago, IL University Hospitals Case Comprehensive Cancer Center, Cleveland, OH

Cleveland Area Attractions


The Cleveland Museum of Art

Newly renovated, The Cleveland Museum of Art features more than 46,000 pieces and work-in-progress galleries.


The Rock and Roll Hall of Fame and Museum

The greatest stories and biggest names in rock and roll shine on at the Rock and Roll Hall of Fame, featuring 4 theaters, multiple interactive stations and seven floors of exhibits.

The Cleveland Metroparks

Get active and live the outdoor life at the Cleveland Metroparks. Explore over 22,000 acres in 18 reservations.

The Cleveland Orchestra

The Cleveland Orchestra is considered one of the nation's best. See a concert at their winter home, Severance Hall, or during summer, listen alfresco at Blossom Music Center.

The Cleveland Sports Scene

Catch an Indians, Cavs, or Browns game- just minutes from Cleveland Clinic!

East 4th Street

From the best food and entertainment the city has to offer to the coolest address in town to live, East 4th Street is an experience you do not want to miss!

Ohio City

Ohio City is considered one of the most diverse and desirable places to live, work, study, play, and worship.

Playhouse Square

The largest performance arts center in the nation outside of New York hosts operas, ballets, concerts and Broadway-style musicals.

The West Side Market

Catch a glimpse of Cleveland's melting pot heritage at this bustling indoor market where vendors sell fruits, veggies, baked goods and more.

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

Referrals

Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2015 Cleveland Clinic. All rights reserved.